Medication info
Corus Acyclovir Tablet

Corus Acyclovir Tablet

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Korea Corus Co., Ltd.
Appearance
Light blue circular tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199402371 · Notified 1994.06.30 · Insurance code 647201000

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes), treatment of herpes zoster, and treatment of chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration, or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection; for recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more prone to adverse reactions in the central nervous system; extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.
Children's dosage
1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg of this drug per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
Korea Corus Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes), treatment of herpes zoster, and treatment of chickenpox in children

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • herpes zoster virus infections
  • acute herpes zoster pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucous membranes, including primary and recurrent genital herpes. It is also particularly effective in relieving acute pain associated with herpes zoster virus infections. However, the efficacy for postherpetic neuralgia is still uncertain. It is also used for the treatment of chickenpox in children over 2 years of age. This medication is available in various forms (tablets, syrup, suspension), allowing for administration suited to the patient's condition. Overall, it is a medication that helps treat viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in cases of severe primary infection. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration, or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection; for recurrent infections, it is preferable to start treatment at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may subsequently be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically stop treatment every 6 ~ 12 months for reassessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug per dose 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered for patients with severe immunodeficiency or gastrointestinal malabsorption. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Use caution in patients with renal impairment, as they are more prone to adverse reactions in the central nervous system; extend the dosing interval or reduce the dose as appropriate. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would accumulate with intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily at approximately 12-hour intervals. 2) For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily at approximately 8-hour intervals.

Children's dosage

1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients Age 2 years and older: Same as adults. Under 2 years: Administer 1/2 the adult dose. There are currently no definitive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg of this drug per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment is most effective when started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medication should not be used in patients who are allergic to this medicine or its ingredients or have previously shown hypersensitivity reactions to valacyclovir. It should be used with caution in patients with impaired kidney function as it carries a higher risk of causing neuropsychiatric adverse reactions. Patients with compromised liver function should also be careful, as this medication may worsen liver function. In infants and children, it should be administered minimally and only when necessary, especially in newborns or low birth weight infants. Elderly patients, who often have reduced kidney function, may have higher blood concentrations of this medication and adverse reactions may be more pronounced, so dosage and administration intervals should be adjusted with adequate fluid intake recommended. Serious allergic reactions such as anaphylactic shock may rarely occur during the administration of this medication, so if symptoms such as hypotension, difficulty breathing, or chest tightness occur, administration should be stopped immediately and appropriate treatment should be sought. Photosensitivity reactions, skin rashes, fever, vesicles, and urticaria-like erythema may occur, and if such symptoms arise, administration should be discontinued and treated. Severe skin diseases such as hair loss, erythema multiforme, Stevens-Johnson syndrome, and Lyell syndrome may occur, so if abnormal symptoms appear, immediate consultation with medical personnel is necessary. Neuropsychiatric side effects can manifest as altered consciousness, disorientation, decreased concentration, aggressive behavior, hallucinations, seizures, drowsiness, insomnia, anxiety, and various other symptoms, being more frequent in elderly patients or those with kidney impairment, and caution is advised. It may affect kidney function, leading to renal failure, hematuria, and proteinuria, so regular kidney function tests should be carried out. Hematologic abnormalities including leukopenia, anemia, bleeding, and purpura can occur, so any unusual symptoms should be reported to a healthcare provider. Hepatic disturbances can lead to hepatitis, jaundice, and elevated liver enzyme levels, so liver function tests should be monitored during use. Gastrointestinal side effects may include gastritis, nausea, vomiting, diarrhea, and abdominal pain, and if symptoms are severe, administration should be discontinued and medical advice sought. Systemic symptoms such as fever, muscle weakness, headache, and malaise can occur, so the patient's condition should be closely monitored. Musculoskeletal symptoms may include arthralgia or myalgia. Cardiovascular side effects such as arrhythmias, blood pressure changes, and chest pain have been reported, so patients with cardiovascular diseases should be cautious. Urogenital side effects such as urinary tract obstruction or difficulty urinating may rarely occur. Other side effects may include pneumonia, pharyngitis, respiratory distress, visual disturbances, taste disorders, hair loss, sweating, and electrolyte imbalances. This medication is most effective when administered as soon as symptoms appear, ideally within 5 days of skin symptom onset for herpes zoster and within 3 days for chickenpox. In patients with compromised immune function, intravenous administration may be considered. During the treatment period, especially at higher doses, sufficient fluid intake should be maintained to reduce the risks of dehydration and kidney toxicity. When treating recurrent genital herpes, it is important to review whether to continue use after a year of therapy. This medication may cause altered consciousness, so caution is advised while driving or operating machinery, especially in patients with kidney impairment. This medication may interact with other drugs, so consultation with healthcare professionals is necessary, particularly when used with probenecid, cimetidine, theophylline, and mycophenolate mofetil. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, and breastfeeding should be stopped during treatment.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • blisters
Show 117 more
  • urticarial rash
  • hives
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing impairment
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • increased total cholesterol levels
  • increased triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • lethargy
  • confusion
  • hallucinations
  • agitation
  • seizure
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. The recommended storage temperature is between 1 to 30 degrees Celsius to maintain the medication's efficacy for a long time.

Appearance and packaging

Appearance

Light blue circular tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.